版本:
中国

BRIEF-Mustang Bio - data presented suggest mb-101 is safe, welltolerated, capable of eliciting a potent anti-tumor response in patients with glioblastoma

Nov 21 Fortress Biotech Inc

* Mustang Bio-phase 1 clinical data and pre-clinical data on its mb-101 for treatment of glioblastoma

* Mustang Bio - data presented suggest mb-101 is safe, welltolerated, capable of eliciting a potent anti-tumor response in patients with glioblastoma Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐